Strata Critical Medical annual ebitda
2019
2020
2021
2022
2023
2024
2025
Strata Critical Medical EBITDA Growth & History (SRTA)
Strata Critical Medical's calculated EBITDA was −$14.2M for fiscal 2025.
View full Strata Critical Medical company overviewStrata Critical Medical annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$14.2M | $2.4M | — |
| 2024 | 2024-12-31 | −$16.6M | $44.4M | — |
| 2023 | 2023-12-31 | −$61.0M | −$13.2M | — |
| 2022 | 2022-12-31 | −$47.8M | — | — |
| 2021 | 2021-09-30 | −$23.5M | −$13.7M | — |
| 2020 · Sep 30 | 2020-09-30 | −$9.8M | $1.2M | — |
| 2019 · Sep 30 | 2019-09-30 | −$11.1M | — | — |
Strata Critical Medical quarterly ebitda
Q1.21
Q2.21
Q4.21
Q1.22
Q2.22
Q3.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.1M | $6.0M | — |
| Q1 2026 | 2026-03-31 | $86,000 | $4.1M | — |
| Q4 2025 | 2025-12-31 | −$3.4M | −$11.5M | — |
| Q3 2025 | 2025-09-30 | −$3.9M | $1.9M | — |
| Q2 2025 | 2025-06-30 | −$2.9M | $7.7M | — |
| Q1 2025 | 2025-03-31 | −$4.0M | $4.3M | — |
| Q4 2024 | 2024-12-31 | $8.1M | $41.9M | — |
| Q3 2024 | 2024-09-30 | −$5.8M | −$208,000 | — |
| Q2 2024 | 2024-06-30 | −$10.6M | −$191,000 | — |
| Q1 2024 | 2024-03-31 | −$8.3M | $2.9M | — |
| Q4 2023 | 2023-12-31 | −$33.8M | −$16.1M | — |
| Q3 2023 | 2023-09-30 | −$5.6M | $3.4M | — |
| Q2 2023 | 2023-06-30 | −$10.4M | −$1.8M | — |
| Q1 2023 | 2023-03-31 | −$11.2M | $1.4M | — |
| Q4 2022 | 2022-12-31 | −$17.7M | −$7.9M | — |
| Q3 2022 · Sep 30 | 2022-09-30 | −$9.0M | $551,000 | — |
| Q3 2022 · Jun 30 | 2022-06-30 | −$8.6M | −$947,000 | — |
| Q2 2022 | 2022-03-31 | −$12.5M | −$8.4M | — |
| Q1 2022 | 2021-12-31 | −$9.8M | — | — |
| Q4 2021 | 2021-09-30 | −$9.5M | — | — |
| Q2 2021 | 2021-06-30 | −$7.6M | — | — |
| Q1 2021 | 2021-03-31 | −$4.1M | — | — |
Strata Critical Medical ebitda trends
Between the periods ended 2019-09-30 and 2025-12-31, Strata Critical Medical's ebitda decreased from −$11.1M to −$14.2M, a change of −$3.1M. The latest reported quarter, Q2 2026, shows $3.1M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Strata Critical Medical source filings ↗